Company

SynaptixBio Ltd.

Biotechnology Research Oxford, Oxfordshire, United Kingdom 5 employees

Employees: 5
Contacts: 2
Emails: 2

www.synaptixbio.com LinkedIn Crunchbase

SynaptixBio Ltd. Overview

Headquarters: Oxford, Oxfordshire, United Kingdom
Website: www.synaptixbio.com
Industry: Biotechnology Research
Employees: 5
Founded: 2021
Funding: 2.6M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Pharmaceutical Biotech Leukodystrophy Rare Disease H-ABC Hypomyelination Basal Ganglia Cerebrllum Neurology Brain Preclincal Drug Discovery

About SynaptixBio Ltd.

Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system.

SynaptixBio Ltd. Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

SynaptixBio Ltd. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Uwe Meya	Semi Retired but Continuing Part-time		View
Laure Humbert	Head of Research and Preclinical	Greater Oxford Area, United Kingdom	Email
Bent Jakobsen	Founder & Chief Executive Officer		View
Michelle Teng	CEO @ Etcembly Ltd. Immune Repertoires	Greater Oxford Area, United Kingdom	Email